Protein 3 Flashcards
- List the sulfer containing amino acids.
methionine
Cysteine
- Describe the biological utility of Cys in regard to its oxidative state (alone or within GSH).
Cysteine is reduced inside oxidized outside
Cysteine plus glycine + glutamate= glutathione
glutathione is reduced by NADPH and used to:
-fight free radicals
-keep proteins in there reduced form
-control how proteins form (chaperones
-regulate hemoglobin, keeps in them in ferrous state
- Describe Met, its relation to SAM and the energy provided in SAM.
Methione makes Sam by SAM synthase and ATP
SAM also called ado met (activated sulfur)
- Describe diseases related to Cys and Met metabolism including hyperhomocysteinemia, homocystinuria, cysteinuria, and vascular disease.
homocysteinuria- defect in CBS enzyme
- Mental retardation
- osteoporosis
- vascular disease
- makes cysteine essential
- a certain subset u can treat with vit b6
Hyper homocysteinuria (from low folate b6 b12) -treat with B vitamins
Cysteinuria- kidney stones (renal failure), due to defective in transporter of cysteine ( Ornithine, Lysine, Arginine) that leads to crystallization (in kidneys), treat with acetazolamide that makes cysteine more soluble
Vascular disease- (from low folate b6 b12)
-treat with B vitamins
- Describe where vitamins are used in Cys and Met metabolism including folate, B6, and B12.
folate and B12 are used in taking homocysteine back to methionine in the methionine synthetase rxn
b6 takes homocysteine to cystathione and cystathione to cysteine
- List biologically important molecules derived from Trp metabolism.
seratonin
niacin
melatonin
dependent on BH4
- Describe diseases related to Phe, Tyr metabolism including phenylketonuria (PKU), tyrosinemia, Parkinson’s disease (PD), and the use of monoamine oxidase (MAO) inhibitors.
Parkinson’s Disease (PD)
- Degenerative disorder of central nervous system (loss of motor skills).
- Loss of neurons–>Low Dopamine–>Parkinson’s
- Treatment
- Treat with Dopa
- Treat with Monoamine oxidase (MAO) inhibitors.
- Treat with catacholamine Mtase inhibitors.